Drug Profile


Alternative Names: 13832 JL; XIFAM

Latest Information Update: 24 Oct 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Logeais
  • Class Antirheumatics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatic disorders

Most Recent Events

  • 24 Oct 1997 Discontinued-Phase-Unspecified for Rheumatic disorders in France (PO)
  • 10 Aug 1995 Suspended-Phase-Unspecified for Rheumatic disorders in France (PO)
  • 08 Dec 1994 A new study involving patients with ankylosing spondylitis has been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top